乳腺筛查钼靶上乳腺癌诊断前的AI风险评分
该回顾性研究利用BreastScreen Norway 2004年1月至2019年12月的影像与筛查信息,对后来确诊乳腺癌女性的既往筛查钼靶由商业AI系统赋予1-7(低风险)、8-9(中风险)、10(高风险)评分。1602例女性(平均59岁)的2787次既往筛查中,筛查检出癌与间期癌在诊断前一轮筛查AI评分为10者分别占38.3%和39.4%;作者认为AI用于钼靶筛查可能使乳腺癌更早检出。
要点
- 筛查检出癌在诊断前一轮筛查中38.3%(389例)AI评分为10。
- 间期癌在诊断前一轮筛查中39.4%(231例)AI评分为10。
- 诊断前两轮(4年)筛查中,筛查检出癌23.0%(122/531)AI评分为10。
核心结论
- 超过三分之一的筛查检出癌和间期癌在既往筛查时即获最高AI风险评分,提示AI用于钼靶筛查可能使乳腺癌更早检出。
研究设计与样本
- 回顾性研究,使用BreastScreen Norway 2004年1月至2019年12月检查的影像数据与筛查信息;共1602例女性(平均年龄59岁±5.1岁[SD])的2787次既往筛查检查,包括筛查检出癌1016例和间期癌586例;由商业AI系统对既往筛查钼靶赋予1-7(低恶性风险)、8-9(中等风险)、10(高恶性风险)评分,并评估基于AI评分的乳腺癌钼靶特征。
关键影像表现/征象
- 筛查检出癌在诊断前一轮筛查钼靶上AI评分为10者占38.3%(389例)。
- 间期癌在诊断前一轮筛查钼靶上AI评分为10者占39.4%(231例)。
- 诊断前两轮筛查(4年)有AI评分的筛查检出癌中,23.0%(122/531)评分为10。
- 浸润性筛查检出癌的钼靶特征与AI评分相关(P < .001)。
- 筛查检出癌AI评分为10者中致密伴钙化占13.6%(43/317),评分为1-7者中占4.6%(15/322)。
诊断标准与关键数值
- AI风险评分1-7为低恶性风险,8-9为中等风险,10为高恶性风险。
临床应用与阅片要点
- 对既往筛查钼靶可参考AI风险评分,评分10提示最高恶性风险。
- 判读时注意致密伴钙化在AI评分10的筛查检出癌中占13.6%,在评分1-7者中占4.6%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Few studies have evaluated the role of artificial intelligence (AI) in prior screening mammography. Purpose To examine AI risk scores assigned to screening mammography in women who were later diagnosed with breast cancer. Materials and Methods Image data and screening information of examinations performed from January 2004 to December 2019 as part of BreastScreen Norway were used in this retrospective study. Prior screening examinations from women who were later diagnosed with cancer were assigned an AI risk score by a commercially available AI system (scores of 1-7, low risk of malignancy; 8-9, intermediate risk; and 10, high risk of malignancy). Mammographic features of the cancers based on the AI score were also assessed. The association between AI score and mammographic features was tested with a bivariate test. Results A total of 2787 prior screening examinations from 1602 women (mean age, 59 years ± 5.1 [SD]) with screen-detected (n = 1016) or interval (n = 586) cancers showed an AI risk score of 10 for 389 (38.3%) and 231 (39.4%) cancers, respectively, on the mammograms in the screening round prior to diagnosis. Among the screen-detected cancers with AI scores available two screening rounds (4 years) before diagnosis, 23.0% (122 of 531) had a score of 10. Mammographic features were associated with AI score for invasive screen-detected cancers (P < .001). Density with calcifications was registered for 13.6% (43 of 317) of screen-detected cases with a score of 10 and 4.6% (15 of 322) for those with a score of 1-7. Conclusion More than one in three cases of screen-detected and interval cancers had the highest AI risk score at prior screening, suggesting that the use of AI in mammography screening may lead to earlier detection of breast cancers. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Mehta in this issue.
引用
- Larsen M, Olstad CF, Koch HW, et al. AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis. Radiology. 2023. PMID: 37847135. doi:10.1148/radiol.230989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。